Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07266376 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS

Study acronym: PROGEVs
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Approximately 25-50% of patients with schizophrenia experience treatment-resistant Auditory Verbal Hallucinations (AVHs), which contribute to the development of associated psychopathological disorders (e.g., anxiety, depression, suicidal ideation). Various validated psychotherapeutic strategies and tools for managing treatment-resistant AVHs have been combined into an integrative therapeutic program. The main objective of this study is to evaluate the efficacy of this program in reducing the frequency and intensity of AVHs, as well as its impact on comorbid psychopathology (e.g., depression, anxiety, self-esteem, substance use) in patients with schizophrenia or schizoaffective disorder who experience treatment-resistant AVHs.
Trial Details
NCT Number NCT07266376
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Collaborators: GIRCI SOHO
Conditions
(from sponsor)		 Mental Disorder, Schizophrenia Diagnosis
Related terms Hallucinations, Mental Disorders, Schizophrenia
Enrollment 116 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov